Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry. [PDF]
Guglielmelli P +17 more
europepmc +1 more source
Megakaryocyte centrosomal and Golgi structural perturbations in patients with primary myelofibrosis and with <i>RUNX1</i> germline mutation. [PDF]
Obiorah IE +6 more
europepmc +1 more source
The treatment of polycythaemia vera: an update in the JAK2 era [PDF]
G. Finazzi +34 more
core +1 more source
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis. [PDF]
Vermeersch G +4 more
europepmc +1 more source
Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source
18F-FDG PET/CT findings in a mucosa-associated lymphoid tissue lymphoma patient coexisting with primary myelofibrosis. [PDF]
Han Y, Wu R, Zhang Y, Zhang X, Gao Z.
europepmc +1 more source
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. [PDF]
Han L +4 more
europepmc +1 more source
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]
Boque, Concepción +4 more
core +1 more source
Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis. [PDF]
Gan X +7 more
europepmc +1 more source

